Pakistan's pharmaceutical industry is set for a major boost as the country expects to attract up to $1 billion in immediate Chinese investment, with the potential to grow to $5 billion over the coming years through new industrial partnerships.

The federal government has invited 130 leading Chinese pharmaceutical and investment companies to participate in an international pharma conference scheduled to be held in Karachi from July 17 to 19. Around 150 Pakistani pharmaceutical, investment, and healthcare-related companies are also expected to attend the event.

Organised under the supervision of the Ministry of National Health Services, the conference will feature dedicated business-to-business (B2B) meetings between Pakistani and Chinese firms for the first time. The discussions will focus on joint ventures, technology transfer, industrial cooperation, and expanding investment opportunities.

According to official sources, several agreements are expected to be signed during the conference for the local production of medical devices, vaccines, pharmaceutical raw materials, surgical instruments, and other healthcare products.

The proposed collaboration also includes the transfer of advanced medical technology and the establishment of joint manufacturing units. In the initial phase, new pharmaceutical manufacturing plants are expected to be set up in Islamabad, Lahore, and Karachi with Chinese support.

The partnership is also likely to expand cooperation in pharmaceutical machinery manufacturing, clinical trials, research and development, and the production of traditional Chinese herbal medicines through joint ventures with Pakistani companies.

Government officials believe the conference will strengthen Pakistan's pharmaceutical industry, increase exports, create employment opportunities, and encourage the adoption of modern healthcare technologies.